1-5 of 5
Marina Djurfeldt, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Pharmacogenetic Study of the NCIC CTG Clinical Trial My.10: Single Nucleotide Polymorphisms, Prognosis, and Predicting Benefit from IMiD® Compound Maintenance Therapy Following Autologous Stem Cell Transplant for Multiple Myeloma

Ming Han, BSc., Alli Murugesan, MSc, PhD, Nizar J Bahlis, MD, Kevin Song, Darrell White, MD MSc, FRCPC, FACP, Christine Chen, MD, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Kang Howsen-Jan, MD, Donna Reece, Keith Stewart, MD, Yagang Xie, MD PhD FCCMG, Annette E Hay, MB ChB, Lois Shepherd, MD, Bingshu E Chen, PhD, Marina Djurfeldt, MSc., Tony Reiman, MD
Journal: Blood
Blood (2015) 126 (23): 2960.
https://doi.org/10.1182/blood.V126.23.2960.2960
Published: 2015
Journal Articles

A Randomized Trial Of Rituximab Vs Observation Following Autologous Stem Cell Transplantation (ASCT) For Relapsed Or Refractory CD20-Positive B Cell Lymphoma: Final Results Of NCIC CTG LY.12

Michael Crump, MD FRCPC, John Kuruvilla, MD, C. Tom Kouroukis, MD, MSc, FRCP(C), Ann Benger, MD, FRCP(C), Matthew C. Cheung, MD, FRCPC, Neil L Berinstein, MD, Stephen Couban, MD, FRCPC, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Kang Howson-Jan, MD, Armand Keating, MD, Massimo Federico, MD, David A Macdonald, MD, FRCPC, Harold J. Olney, MD, Morel Rubinger, MD, Michael Voralia, A. Robert Turner, MD, FRCPC, Tara Baetz, MD, Annette E Hay, MBChB, Marina Djurfeldt, MSc, Ralph M. Meyer, MD, Bingshu Chen, PhD, Lois Shepherd, M.D.
Journal: Blood
Blood (2013) 122 (21): 155.
https://doi.org/10.1182/blood.V122.21.155.155
Published: 2013
Journal Articles

Gemcitabine, Dexamethasone, Cisplatin (GDP) Compared to Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Prior to Autologous Stem Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: Final Results of the Randomized Phase III NCIC CTG Study LY12

Michael Crump, MD, FRCPC, John Kuruvilla, MD, FRCPC, Stephen Couban, MD, FRCPC, David Macdonald, MD, FRCPC, Vishal Kukreti, MD, C. Tom Kouroukis, MD, MSc, FRCPC, Ralph M. Meyer, MD, Morel Rubinger, MD, Rena Buckstein, MD, Kevin R Imrie, MD, Massimo Federico, MD, Nicola Di Renzo, MD, Kang Howson-Jan, MD, Tara Baetz, MD, Leonard Kaizer, MD FRCPC, Michael Voralia, MD, FRCPC, Harold J. Olney, MD, A. Robert Turner, MD, FRCPC, Jonathan Sussman, MD, Annette E Hay, MBChB, Marina Djurfeldt, MSc, Bingshu E Chen, PhD, Lois Shepherd, MD
Journal: Blood
Blood (2012) 120 (21): 745.
https://doi.org/10.1182/blood.V120.21.745.745
Published: 2012
Journal Articles

Bortezomib Added to CVP-R Is Safe and Effective for Previously Untreated Advanced Stage Follicular Lymphoma: A Phase II Study by the NCIC Clinical Trials Group.

Laurie H. Sehn, MD, MPH, David A Macdonald, MD, Sheldon H. Rubin, MD, Guy Cantin, MD, Morel Rubinger, MD, Bernard Lemieux, MD, Sanraj Basi, MD, Kevin R Imrie, MD, Randy D. Gascoyne, Bingshu Chen, PhD, Marina Djurfeldt, MSc, Lois Shepherd, MD, Stephen Couban, MD, Michael Crump, MD
Journal: Blood
Blood (2009) 114 (22): 407.
https://doi.org/10.1182/blood.V114.22.407.407
Published: 2009
Journal Articles

Outcomes of Previously Untreated Older Patients with Multiple Myeloma (MM) over Time: An Analysis of 3 Consecutive Trials Conducted by the NCIC CTG, 1983–2003.

Cynthia Luk, MD, Keyue Ding, PhD, Andrew R. Belch, MD, George P. Browman, MD, Chaim Shustik, MD, Marina Djurfeldt, MSc, Dianne Johnston, Lois E. Shepherd, MD, Ralph M. Meyer, MD
Journal: Blood
Blood (2005) 106 (11): 2568.
https://doi.org/10.1182/blood.V106.11.2568.2568
Published: 2005